NexGel Inc. Insider Trading

NXGL

Last 12 months

Insiders sold 47K and bought nothing on the open market.

22% of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in Nov 2024.

Net open-market

−47K

0 buys · 7 sales

Under a 10b5-1 plan

22%

of the value sold

Insiders who bought / sold

0 / 1

executives and directors

Last open-market buy

Nov 2024

Nov 20, 2024

Get an email when NXGL's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jun 18 – 23	Adam R. Levy Chief Executive Officer	SoldNo plan 2 parts	11,000	$0.59 average	6K	3.3%	Form 4
Jun 11	Adam R. Levy Chief Executive Officer	SoldNo plan	3,000	$0.61	2K	0.9%	Form 4
Jun 4 – 8	Adam R. Levy Chief Executive Officer	SoldNo plan 2 parts	6,000	$0.57 average	3K	1.8%	Form 4
Jun 1	Adam R. Levy Chief Executive Officer	SoldNo plan	2,000	$0.59	1K	0.6%	Form 4
May 27 – 29	Adam R. Levy Chief Executive Officer	SoldNo plan 3 parts	13,000	$0.61 average	8K	3.6%	Form 4
Dec 22, 2025 – Dec 24, 2025	Adam R. Levy Chief Executive Officer	SoldNo plan 2 parts	10,000	$1.59 average	16K	2.7%	Form 4
Nov 6, 2025	Adam R. Levy Chief Executive Officer	Sold10b5-1 plan	4,000	$2.52	10K	1.1%	Form 4
Oct 2, 2025 – Oct 3, 2025	Scott Robert Henry Director	Sold10b5-1 plan 2 parts	8,000	$2.54 average	20K	6.6%	Form 4
Oct 2, 2025 – Oct 3, 2025	Adam R. Levy Chief Executive Officer	Sold10b5-1 plan 2 parts	4,000	$2.53 average	10K	1.1%	Form 4
Sep 25, 2025	Scott Robert Henry Director	Sold10b5-1 plan	7,697	$2.36	18K	6.0%	Form 4
Aug 28, 2025	Adam R. Levy Chief Executive Officer	SoldNo plan	4,000	$2.47	10K	1.1%	Form 4
Jun 13, 2025	Scott Robert Henry Director	Sold10b5-1 plan	3,000	$2.57	8K	2.3%	Form 4
Jun 9, 2025 – Jun 11, 2025	Adam R. Levy Chief Executive Officer	SoldNo plan 2 parts	4,000	$2.36 average	9K	1.1%	Form 4
Jun 4, 2025 – Jun 5, 2025	Adam R. Levy Chief Executive Officer	SoldNo plan 2 parts	2,000	$2.31 average	5K	0.5%	Form 4
May 30, 2025	Adam R. Levy Chief Executive Officer	SoldNo plan	1,000	$2.22	2K	0.3%	Form 4
May 16, 2025	Adam R. Levy Chief Executive Officer	SoldNo plan	1,000	$2.58	3K	0.3%	Form 4
May 12, 2025	Scott Robert Henry Director	Sold10b5-1 plan	3,000	$2.69	8K	2.2%	Form 4
Apr 10, 2025	Scott Robert Henry Director	Sold10b5-1 plan	3,000	$2.61	8K	2.2%	Form 4
Apr 1, 2025	Adam R. Levy Chief Executive Officer	Sold10b5-1 plan	4,000	$3.01	12K	1.1%	Form 4
Mar 10, 2025	Scott Robert Henry Director	Sold10b5-1 plan	3,000	$2.87	9K	2.1%	Form 4
Mar 3, 2025	Adam R. Levy Chief Executive Officer	Sold10b5-1 plan	4,000	$3.16	13K	1.1%	Form 4
Feb 10, 2025	Scott Robert Henry Director	Sold10b5-1 plan	3,000	$3.27	10K	2.1%	Form 4
Feb 3, 2025	Adam R. Levy Chief Executive Officer	Sold10b5-1 plan	4,000	$3.64	15K	1.0%	Form 4
Jan 7, 2025	Scott Robert Henry Director	Sold10b5-1 plan	3,000	$3.37	10K	2.1%	Form 4
Jan 2, 2025	Adam R. Levy Chief Executive Officer	Sold10b5-1 plan	4,000	$3.96	16K	0.5%	Form 4
Dec 20, 2024	Scott Robert Henry Director	Sold10b5-1 plan	3,000	$4.64	14K	2.0%	Form 4
Nov 20, 2024	Steven Mark Glassman Director	Bought	9,090	$2.75	25K	6.3%	Form 4
Nov 20, 2024	Scott Robert Henry Director	Bought	1,818	$2.75	5K	1.2%	Form 4
Nov 20, 2024	John Nachum Stein Director	Bought	3,636	$2.75	10K	0.8%	Form 4
Nov 20, 2024	Jerome B Zeldis Director	Bought	3,636	$2.75	10K	3.5%	Form 4
Nov 20, 2024	Adam R. Levy Chief Executive Officer	Bought	3,636	$2.75	10K	1.1%	Form 4
Nov 20, 2024	Adam E Drapczuk III Chief Financial Officer	Bought	17,500	$2.75	48K	21%	Form 4

Jun 18 – 23No plan
Adam R. Levy
Chief Executive Officer · sold 11,000 at avg $0.59
6K
3.3% of stake
Jun 11No plan
Adam R. Levy
Chief Executive Officer · sold 3,000 at $0.61
2K
0.9% of stake
Jun 4 – 8No plan
Adam R. Levy
Chief Executive Officer · sold 6,000 at avg $0.57
3K
1.8% of stake
Jun 1No plan
Adam R. Levy
Chief Executive Officer · sold 2,000 at $0.59
1K
0.6% of stake
May 27 – 29No plan
Adam R. Levy
Chief Executive Officer · sold 13,000 at avg $0.61
8K
3.6% of stake
Dec 22, 2025 – Dec 24, 2025No plan
Adam R. Levy
Chief Executive Officer · sold 10,000 at avg $1.59
16K
2.7% of stake
Nov 6, 202510b5-1 plan
Adam R. Levy
Chief Executive Officer · sold 4,000 at $2.52
10K
1.1% of stake
Oct 2, 2025 – Oct 3, 202510b5-1 plan
Scott Robert Henry
Director · sold 8,000 at avg $2.54
20K
6.6% of stake
Oct 2, 2025 – Oct 3, 202510b5-1 plan
Adam R. Levy
Chief Executive Officer · sold 4,000 at avg $2.53
10K
1.1% of stake
Sep 25, 202510b5-1 plan
Scott Robert Henry
Director · sold 7,697 at $2.36
18K
6.0% of stake
Aug 28, 2025No plan
Adam R. Levy
Chief Executive Officer · sold 4,000 at $2.47
10K
1.1% of stake
Jun 13, 202510b5-1 plan
Scott Robert Henry
Director · sold 3,000 at $2.57
8K
2.3% of stake
Jun 9, 2025 – Jun 11, 2025No plan
Adam R. Levy
Chief Executive Officer · sold 4,000 at avg $2.36
9K
1.1% of stake
Jun 4, 2025 – Jun 5, 2025No plan
Adam R. Levy
Chief Executive Officer · sold 2,000 at avg $2.31
5K
0.5% of stake
May 30, 2025No plan
Adam R. Levy
Chief Executive Officer · sold 1,000 at $2.22
2K
0.3% of stake
May 16, 2025No plan
Adam R. Levy
Chief Executive Officer · sold 1,000 at $2.58
3K
0.3% of stake
May 12, 202510b5-1 plan
Scott Robert Henry
Director · sold 3,000 at $2.69
8K
2.2% of stake
Apr 10, 202510b5-1 plan
Scott Robert Henry
Director · sold 3,000 at $2.61
8K
2.2% of stake
Apr 1, 202510b5-1 plan
Adam R. Levy
Chief Executive Officer · sold 4,000 at $3.01
12K
1.1% of stake
Mar 10, 202510b5-1 plan
Scott Robert Henry
Director · sold 3,000 at $2.87
9K
2.1% of stake
Mar 3, 202510b5-1 plan
Adam R. Levy
Chief Executive Officer · sold 4,000 at $3.16
13K
1.1% of stake
Feb 10, 202510b5-1 plan
Scott Robert Henry
Director · sold 3,000 at $3.27
10K
2.1% of stake
Feb 3, 202510b5-1 plan
Adam R. Levy
Chief Executive Officer · sold 4,000 at $3.64
15K
1.0% of stake
Jan 7, 202510b5-1 plan
Scott Robert Henry
Director · sold 3,000 at $3.37
10K
2.1% of stake
Jan 2, 202510b5-1 plan
Adam R. Levy
Chief Executive Officer · sold 4,000 at $3.96
16K
0.5% of stake
Dec 20, 202410b5-1 plan
Scott Robert Henry
Director · sold 3,000 at $4.64
14K
2.0% of stake
Nov 20, 2024
Steven Mark Glassman
Director · bought 9,090 at $2.75
25K
6.3% of stake
Nov 20, 2024
Scott Robert Henry
Director · bought 1,818 at $2.75
5K
1.2% of stake
Nov 20, 2024
John Nachum Stein
Director · bought 3,636 at $2.75
10K
0.8% of stake
Nov 20, 2024
Jerome B Zeldis
Director · bought 3,636 at $2.75
10K
3.5% of stake
Nov 20, 2024
Adam R. Levy
Chief Executive Officer · bought 3,636 at $2.75
10K
1.1% of stake
Nov 20, 2024
Adam E Drapczuk III
Chief Financial Officer · bought 17,500 at $2.75
48K
21% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch NXGL, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with NXGL

CompareIntrinsic value

ALURAllurion Technologies Inc.

$0.02+0.00%10

NSPRInspireMD Inc.

$0.78+18.33%25

MDNCMedinotec Inc.

No recent price65

NMTCNeuroOne Medical Technologies Corporation

$0.95-3.06%40

MDAISpectral AI Inc.

$1.53+2.00%10

BTCYBiotricity Inc.

$0.06+1.29%64

XAIRBeyond Air, Inc.

$2.33+0.43%30

IVFINVO Fertility, Inc.

$2.05+5.67%40

Spot a number that looks wrong? Check it in NXGL's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing NXGL

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.